Therapeutic Indication
| Type 2 Diabetes Mellitus (T2DM) |
| Reduction of cardiovascular risk in diabetic patients |
| Adjunct therapy with diet and exercise |
| Combination therapy with other antidiabetic agents |
Dapagliflozin
Tablet
Dapagliflozin propanediol Tablet contains Dapagliflozin, a potent, highly selective, and orally active inhibitor of the human renal sodium-glucose cotransporter 2 (SGLT2), the major transporter responsible for renal glucose reabsorption. It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dapagliflozin works on our kidneys to increase the amount of sugar that our body removes in urine. Due to its protective effects on the kidneys and heart, It can also be used to treat chronic kidney disease and certain types of heart failure.
| Speciality | SGLT2 Inhibitor Antidiabetic |
|---|---|
| Tags | Diabetes | Blood Sugar Control | SGLT2 Inhibitor |
| Strength |
|
| Packing Size |
|